Bayer can claim the title of the most valuable German industrial corporation since August of last year.
The chemical and pharmaceutical giant won an additional €9 billion, or $9.8 billion, in market capitalization in 2014, and another €20 billion since the beginning of 2015. Currently, it is worth about €114 billion.
The company’s shareholders have little reason to complain when they meet on Wednesday at the Bayer annual general meeting. It appears as if the Bayer chief executive, Marijn Dekkers, is doing almost everything right, from the research and marketing strategy in the pharmaceutical business up to the planned spin-off of the plastics division, Bayer Material Science.